The Multi-center Study of Comprehensive Atrial Fibrillation Regurgitation by 3-dimensional Transoesophageal Echocardiography and Recurrent Events Evaluation

Status: Recruiting
Location: See location...
Study Type: Observational
SUMMARY

Atrial fibrillation (AF) is the most common cardiac arrhythmia in the clinic and can lead to valve regurgitation and a poor prognosis. At present, atrial fibrillation ablation is one of the most effective means for the recurrence of atrial fibrillation in clinical practice, but the recurrence rate is high. Therefore, it is of great significance to find the predictors of relapse after atrial fibrillation ablation for clinical precision treatment. three-dimensional transesophageal ultrasound (3D-TEE) can comprehensively evaluate the valve regurgitation, flap ring changes, atrial or auricular thrombosis in patients with atrial fibrillation. It is also a necessary examination before atrial fibrillation ablation. Therefore, this study intends to combine 3D-TEE and three-dimensional transthoracic echocardiographic (3D-TTE) examination to evaluate the cardiac structure and function of patients. To comprehensively evaluate atrial fibrillation valve regurgitation and explore the predictors of recurrence after atrial fibrillation ablation.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
View:

• Age ≥18 years old;

• Patients who came to the hospital with atrial fibrillation and intended to undergo ablation.

Locations
Other Locations
China
First Hospital of China Medical University
RECRUITING
Shenyang
Contact Information
Primary
Chunyan Ma, Doctor
cmu1h_mcy@126.com
13998816448
Time Frame
Start Date: 2024-12-30
Estimated Completion Date: 2026-09-30
Participants
Target number of participants: 2000
Treatments
AF group
Sponsors
Leads: First Hospital of China Medical University

This content was sourced from clinicaltrials.gov